Recent News

• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
• 08.05.2025 - Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.05.2025 - Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 07.30.2025 - Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
• 07.30.2025 - Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
• 06.13.2025 - Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
• 06.13.2025 - Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

Recent Filings

• 08.05.2025 - 8-K Current report
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.05.2025 - EX-99.1 EX-99.1
• 07.09.2025 - 8-K Current report
• 06.13.2025 - 8-K Current report
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 8-K Current report